Clinical Trials on Moderate to Severe Atopic Eczema

Total 1644 results

Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Atopic Dermatitis (AD)

Japan
Ethicon, Inc.

Recruiting

The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study

Controlling Mild to Moderate Bleeding During Surgery

United States, United Kingdom
Edwards Lifesciences

Terminated

Hypotension Prediction Index (HPI) SMART-BP Trial

Moderate to High-risk Noncardiac Surgery

United States
Etwal Ltd.

Completed

Determination of the Efficacy and Safety of Psirelax in the Relief of the Disease in Psoriasis

Mild to Moderate Psoriasis

Israel
AbbVie

Active, not recruiting

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Atopic Dermatitis (AD)

China
Ganzhou Hemay Pharmaceutical Co., Ltd

Completed

A Study of Hemay005 in Adult With Atopic Dermatitis

Hemay005, Atopic Dermatitis

China
National Institute of Allergy and Infectious Diseases...
Sanofi; Regeneron Pharmaceuticals; Rho Federal Systems Division, Inc.; Atopic Dermatitis...

Terminated

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Atopic Dermatitis (AD)

United States
AbbVie

Withdrawn

A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Atopic Dermatitis (AD)
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Atopic Dermatitis (AD)

United States, Canada
National Polytechnic Institute, Mexico
Hospital Infantil de Mexico Federico Gomez; Instituto de Oftalmología Fundación...

Completed

Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis

Childhood Atopic Dermatitis

Mexico
ASST Fatebenefratelli Sacco

Completed

Probiotics in Adults: do They Improve Atopic Dermatitis?

Adult Atopic Dermatitis

Italy
Delenex Therapeutics AG

Completed

Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (2011-00500-15)

Mild-to-moderate Psoriasis Vulgaris

Austria, Germany
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Amgen

Completed

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic Dermatitis

Canada, United States, Japan
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Atopic Dermatitis (AD)

United States
Yuzuncu Yıl University

Completed

Effect of Probiotics in the Atopic Dermatitis

Atopic Dermatitis, Probiotics
Siriraj Hospital

Completed

Knowledge Base in the Treatment of Atopic Dermatitis Among Thai Pediatricians

Childhood Atopic Dermatitis

Thailand
OrchestratePharma GmbH
VidiLife Clinical Research Associate

Completed

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% (ATOFEX-1)

Psoriasis | Eczema | Pruritus | Atopic Dermatitis | Psoriasis Vulgaris | Urticaria | Skin Rash | Urticaria Chronic | Skin Inflammation | Atopic Dermatitis Eczema | Rash | Atopic Rash

Bangladesh
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Completed

Atopic Dermatitis (AD) and Food Allergy

Atopic Dermatitis (AD) | Non-atopic Healthy Controls

United States
UCB Biopharma S.P.R.L.

Completed

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Moderate and Severe Active Rheumatoid Arthritis | Active Psoriatic Arthritis | Active Ankylosing Spondylitis | Moderately to Severely Active Crohn's Disease

United States
Nu Eyne Co., Ltd.

Recruiting

Study of Application of Transcutaneous Pulsed Electrical Stimulation Around Eye in Age-related Macular Degeneration

Early to Moderate Dry Age-Related Macular Degeneration

Korea, Republic of
Cadila Pharnmaceuticals
Lipidor AB, Svärdvägen 13 SE-182 33 Danderyd, Sweden

Completed

A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis (AKP01)

Mild to Moderate Plaque Psoriasis

India
National Nutrition and Food Technology Institute

Unknown

Effects of Saffron on Mild to Moderate Generalized Anxiety Disorder (GAD)

Patients With Mild to Moderate GAD
Novartis

Completed

Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension

Essential Hypertension ( Mild to Moderate)

Romania, Slovakia, Hungary, France
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Completed

Interferon Responses in Eczema Herpeticum (ADRN-01)

Atopic Dermatitis | Herpes Simplex Infections | Eczema Herpeticum | Eczema Vaccinatum

United States
GWT-TUD GmbH
Novartis Pharmaceuticals

Completed

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis (Secu_in_AD)

Dermatitis, Atopic | Eczema, Atopic | Neurodermatitis, Atopic

Germany
Bristol-Myers Squibb

Completed

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis

Healthy Subjects and Atopic Dermatitis Subjects

United Kingdom
Merz North America, Inc.
Ulthera, Inc

Completed

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients (ULT-302)

Mild to Moderate Skin Laxity Under the Chin | Mild to Moderate Skin Laxity on Neck

United States
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Healthy Participants | Atopic Dermatitis Patients

China
The University of Hong Kong
Guang'anmen Hospital of China Academy of Chinese Medical Sciences; The First... and other collaborators

Completed

Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS). (TECAS)

Mild-to-moderate Depression

China
PiLeJe

Completed

Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.

Mild to Moderate Depression

France
Ahram Canadian University

Terminated

Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

Chronic Atopic Dermatitis

Egypt
University of North Carolina, Chapel Hill

Completed

Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on Eczema

Eczema | Atopic Dermatitis | Atopic Dermatitis and Related Conditions

United States
Spirig Pharma Ltd.

Completed

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

Skin Alterations Associated With Atopic Dermatitis

Germany
Yuzuncu Yıl University

Completed

Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic Dermatitis

Atopic Dermatitis, Serum Skin Test
Ipsen

Terminated

Study to Evaluate the Safety and Efficacy of IPN59011 in Improving the Appearance of Moderate to Severe Upper Facial Lines. (LONG-SET)

Moderate Upper Facial Lines | Severe Upper Facial Lines

Germany
Yooyoung Pharmaceutical Co., Ltd.

Completed

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds

Korea, Republic of
Kintsugi Mindful Wellness, Inc.
Sonar Strategies; Vituity Psychiatry

Recruiting

Kintsugi Voice Device Pilot Study

Depression | Depression Moderate | Depression Severe | Depression Mild

United States
Bar-Ilan University, Israel
University of California, Berkeley; United States - Israel Binational Science...

Recruiting

Personalized Need-focused Single Session Intervention

Depression and/or Anxiety in the Mild-to-moderate Range

United States, Israel
Fundació Sant Joan de Déu

Unknown

Cost-effectiveness of a Non-Pharmacological Treatment (Active Monitoring) vs. a Pharmacological Treatment for Major Depression in Primary Care.

Mild to Moderate Depression.
Eisai Inc.

Completed

Evaluating the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy

Mild to Moderate Diabetic Sensorimotor Polyneuropathy

United States
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Completed

Targeted Microbiome Transplant in Atopic Dermatitis

Atopic Dermatitis (AD)

United States
Institut de Sante Publique, d'Epidemiologie et...

Completed

Effectiveness of Care Management in Alzheimer Patients (AIDALZ)

Alzheimer Disease or Associated Disorder | Mild to Moderately Severe Dementia

France
University Ghent
Universiteit Antwerpen; Janssen-Cilag Ltd.

Recruiting

Integrated Depression Care (IDECA)

Depression Moderate | Depression Severe | Depression Mild

Belgium
Bionorica SE

Completed

Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis

Eczema-Prone Skin | Atopic Diathesis

Germany
OrthoTrophix, Inc

Completed

A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees

Mild to Moderate Knee OA

United States
Incyte Corporation

Active, not recruiting

Study of Ruxolitinib Cream in Adolescents With Atopic Dermatitis

Atopic Dermatitis (AD)

Canada, United States, Poland
EMS

Not yet recruiting

Efficacy and Safety of DIT112 in the Treatment of Moderate to Severe Pain After Dental Surgery for the Extraction of Impacted Third Molars (ALIV)

Moderate Pain | Severe Pain
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients

Active Moderate to Severe Graves' Orbitopathy

Clinical Trials on Moderate to Severe Atopic Eczema

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations